RAFAEL VÍCTOR
ARROYO GONZÁLEZ
Investigador en el periodo 2009-2016
Xavier
Montalbán Gairín
Publicaciones en las que colabora con Xavier Montalbán Gairín (42)
2023
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2017
-
Metabolomic signatures associated with disease severity in multiple sclerosis
Neurology: Neuroimmunology and NeuroInflammation, Vol. 4, Núm. 2
-
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Annals of Neurology, Vol. 82, Núm. 1, pp. 20-29
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Respuesta al tratamiento con interferón beta en pacientes con esclerosis múltiple. Validación del Rio Score
Revista de Neurologia, Vol. 63, Núm. 4, pp. 145-150
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
-
Influence of the LILRA3 deletion on multiple sclerosis risk: Original data and meta-analysis
PLoS ONE, Vol. 10, Núm. 8
-
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457
-
Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283
-
Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)
Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224
2014
-
Biomarkers in multiple sclerosis: An update for 2014
Revista de Neurologia, Vol. 58, Núm. 12, pp. 553-570
-
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-ß therapy in multiple sclerosis
Journal of Medical Genetics, Vol. 51, Núm. 6, pp. 395-400
-
Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis
Annals of Neurology, Vol. 76, Núm. 2, pp. 231-240